CRAIG LOGSDON to Calcium-Binding Proteins
This is a "connection" page, showing publications CRAIG LOGSDON has written about Calcium-Binding Proteins.
Connection Strength
1.550
-
Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy. Mol Cancer Ther. 2013 May; 12(5):654-62.
Score: 0.355
-
S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis. Clin Cancer Res. 2012 Aug 15; 18(16):4356-64.
Score: 0.342
-
S100P: a novel therapeutic target for cancer. Amino Acids. 2011 Oct; 41(4):893-9.
Score: 0.296
-
S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res. 2005 Aug 01; 11(15):5356-64.
Score: 0.212
-
S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem. 2004 Feb 13; 279(7):5059-65.
Score: 0.188
-
The induction of S100p expression by the Prostaglandin E2 (PGE2)/EP4 receptor signaling pathway in colon cancer cells. Cancer Biol Ther. 2010 Nov 15; 10(10):1056-66.
Score: 0.077
-
RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum. 2007 Aug; 50(8):1230-40.
Score: 0.061
-
Regulator of calcineurin 1 controls growth plasticity of adult pancreas. Gastroenterology. 2010 Aug; 139(2):609-19, 619.e1-6.
Score: 0.019